... of late-stage breast cancers that have spread to other parts of the body (metastatic breast cancers) are characterised by overexpression of the protein Mdm2. Lindsey Mayo and colleagues, ... drives this increased Mdm2 expression and found that Mdm2 helps promote cancer cells take on more aggressive characteristics, making it a potential target for drugs to treat late-stage metastatic breast cancer...

I’ve been reviewing online sites to ferret out those that pertain specifically to metastatic breast cancer. I have found a few support sites devoted to MBC, so I’m including them here as well as in my links. Here are three. To join any of these support groups, simply complete the ten-second registration process. The Advanced Breast

... downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. ... In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-B activation ... inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.

Background: This phase II study evaluated the clinical benefit of pegylated liposomal doxorubicin (PLD) and docetaxel (Taxotere) as first-line therapy for metastatic breast cancer (MBC). Patients and methods: MBC patients were enrolled to receive six cycles of PLD 35 mg/m2 (day 1) and docetaxel 40 mg/m2 (days 1 and 15), every 28 days (group A ...

... pain, warmth, swelling, redness throughout the breast and an orange peel texture to the skin, which is referred to as peau ... chills. Pain in the joints can be manifestations of metastatic breast cancer. Jaundice and neurological symptoms, too, could point ... resources to deal with this time are books. You could consider Secrets of Cancer Survivors by Elizabeth Gould. For more information, please click ...

... issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells. Link: 

... ) and bone marrow disseminated tumor cells (DTCs) in breast cancer patients is associated with a high incidence of disease relapse and ... kinase (pFAK) in CTCs from 34 patients with metastatic breast cancer who had detectable CK-19 mRNA-positive CTCs ... VEGF and VEGFR2 in CTCs of patients with metastatic breast cancer could explain the metastatic potential of these cells and may provide a therapeutic ...

An experimental drug reduced the spread of breast cancer into bone in mice, researchers say. The drug -- Y27632 -- inhibits a protein called Rho-associated kinase (ROCK), which is over-produced in metastatic breast cancer. Inhibiting ROCK in the earliest stages of breast cancer ... of cancer spread (metastasis) by 36 percent and decreased metastatic tumor mass in bone by 77 percent, the researchers ...

... many people each year? Indeed, the USPSTF has remained neutral on many cancer-screening recommendations; they conclude there is insufficient evidence to ... ambivalent; I reviewed the literature on CT for lung cancer screening and concluded it is neither effective nor cost-effective.) ... 've all seen that unfortunate 45 year old who has metastatic breast cancer); don't use a gut feeling. Use real ...

... invasive, mesenchymal phenotype of CD44posCD24neg breast cancer cells has made them a promising target for eliminating the metastatic capacity of primary tumors. It has been previously demonstrated that CD44neg/ ... . Results: CD24 expression was dynamically regulated in vitro in all evaluated breast cancer cell lines. Furthermore, a single noninvasive, epithelial-like ...